Moreno, C. A. M., Artilheiro, M. C., Fonseca, A. T. Q. S. M., da Silva, A. M. S., Fernandes, T. R., Camelo, C. G., Paiva, M. A., di Pace, F. T., Pessoa, A. L. S., Braga, V. L. L., Mariano, T. C., de Paula Estephan, E., da Penha Morita, M., Covaleski, A. P. P. M., Van der Linden, V., Tomaselli, P. J., Scarpellini, G. R., Gurgel-Giannetti, J., Sobrinho, L. M. F., … Zanoteli, E. (2025). Clinical and molecular spectrum of TK2-deficiency: a large Brazilian cohort. Scientific Reports, 15(1). https://doi.org/10.1038/s41598-024-84373-5

Kater, A. P., Harrup, R. A., Kipps, T. J., Eichhorst, B., Owen, C., Assouline, S. E., Lamanna, N., Robak, T., de la Serna, J., Jaeger, U., Cartron, G., Montillo, M., Mellink, C., Langerak, A. W., Chyla, B., Popovic, R., Jiang, Y., Millen, R., Lefebure, M., … Seymour, J. F. (2025). The MURANO study: final analysis and retreatment/crossover substudy results of VenR for patients with relapsed/refractory CLL. Blood Journal. https://doi.org/10.1182/blood.2024025525

Molinsky, R. L., Shah, A., Yuzefpolskaya, M., Yu, B., Misialek, J. R., Bohn, B., Vock, D., MacLehose, R., Borlaug, B. A., Colombo, P. C., Ndumele, C. E., Ishigami, J., Matsushita, K., Lutsey, P. L., & Demmer, R. T. (2025). Infection‐Related Hospitalization and Incident Heart Failure: The Atherosclerosis Risk in Communities Study. Journal of the American Heart Association. https://doi.org/10.1161/jaha.123.033877

Geng, J., Ruan, X., Wu, X., Chen, X., Fu, T., Gill, D., Burgess, S., Chen, J., Ludvigsson, J. F., Larsson, S. C., Li, X., Du, Z., & Yuan, S. (2024). Network Mendelian randomisation analysis deciphers protein pathways linking type 2 diabetes and gastrointestinal disease. Diabetes, Obesity and Metabolism. Portico. https://doi.org/10.1111/dom.16087

Martinez‐Morata, I., Domingo‐Relloso, A., Zhang, Y., Fretts, A. M., Pichler, G., Garcia Pinilla, J. M., Umans, J. G., Cole, S. A., Sun, Y., Shimbo, D., Navas‐Acien, A., & Devereux, R. B. (2024). Heart Failure Risk Prediction in a Population With a High Burden of Diabetes: Evidence From the Strong Heart Study. Journal of the American Heart Association, 13(17). https://doi.org/10.1161/jaha.123.033772

Calì, F., Ladanyi, A., Pinsino, A., Antler, K., Murphy, J., Mondellini, G. M., Kaku, Y., Sayer, G., Uriel, N., Takeda, K., Colombo, P. C., Jennings, D., & Yuzefpolskaya, M. (2024). Sodium Glucose Co-Transporter 2 Inhibitor Use in HeartMate 3 Patients. The Journal of Heart and Lung Transplantation, 43(4), S647. https://doi.org/10.1016/j.healun.2024.02.1028

GOYAL, P., DIDOMENICO, R. J., PRESSLER, S. J., IBEH, C., WHITE-WILLIAMS, C., ALLEN, L. A., GORODESKI, E. Z., Albert, N., Fudim, M., Lekavich, C., Watson, K., Gulati, S., Kalogeropoulos, A., & Lewsey, S. (2024). Cognitive Impairment in Heart Failure: A Heart Failure Society of America Scientific Statement. Journal of Cardiac Failure, 30(3), 488–504. https://doi.org/10.1016/j.cardfail.2024.01.003

Romiti, G. F., Nabrdalik, K., Corica, B., Bucci, T., Proietti, M., Qian, M., Chen, Y., Thompson, J. L. P., Homma, S., & Lip, G. Y. H. (2024). Diabetes mellitus in patients with heart failure and reduced ejection fraction: a post hoc analysis from the WARCEF trial. Internal and Emergency Medicine, 19(4), 931–939. https://doi.org/10.1007/s11739-024-03544-4

Diamond, J. M., Benvenuto, L., Claridge, T., Witek, S., Christie, J. D., Singer, J. P., & Anderson, M. R. (2024). Provider beliefs and practices regarding the management of obesity in lung transplant recipients. JHLT Open, 3, 100028. https://doi.org/10.1016/j.jhlto.2023.100028

Prasad, P., & Prasad, M. (2024). In Reply: Should I start an SGLT-2 inhibitor in my patient with heart failure and chronic kidney disease? Cleveland Clinic Journal of Medicine, 91(2), 82.2-83. https://doi.org/10.3949/ccjm.91c.02002

Rasouli, N., Younes, N., Ghosh, A., Albu, J., Cohen, R. M., DeFronzo, R. A., Diaz, E., Sayyed Kassem, L., Luchsinger, J. A., McGill, J. B., Sivitz, W. I., Tamborlane, W. V., Utzschneider, K. M., Kahn, S. E., Crandall, J. P., McKee, M. D., Behringer-Massera, S., Brown-Friday, J., … Xhori, E. (2024). Longitudinal Effects of Glucose-Lowering Medications on β-Cell Responses and Insulin Sensitivity in Type 2 Diabetes: The GRADE Randomized Clinical Trial. Diabetes Care, 47(4), 580–588. https://doi.org/10.2337/dc23-1070

Rothberg, A., Lean, M., & Laferrère, B. (2024). Remission of type 2 diabetes: always more questions, but enough answers for action. Diabetologia, 67(4), 602–610. https://doi.org/10.1007/s00125-023-06069-1

Miljkovic, I., Cvejkus, R., Andersen, S., Cosentino, S., & Zmuda, J. (2023). MARKERS OF GLUCOSE METABOLISM ARE ASSOCIATED WITHCCOGNITIVE DECLINE AMONG FAMILIES WITH EXCEPTIONAL SURVIVAL. Innovation in Aging, 7(Supplement_1), 918–918. https://doi.org/10.1093/geroni/igad104.2951

Khera, R., Dhingra, L. S., Aminorroaya, A., Li, K., Zhou, J. J., Arshad, F., Blacketer, C., Bowring, M. G., Bu, F., Cook, M., Dorr, D. A., Duarte-Salles, T., DuVall, S. L., Falconer, T., French, T. E., Hanchrow, E. E., Horban, S., Lau, W. C., Li, J., … Suchard, M. A. (2023). Multinational patterns of second line antihyperglycaemic drug initiation across cardiovascular risk groups: federated pharmacoepidemiological evaluation in LEGEND-T2DM. BMJ Medicine, 2(1), e000651. https://doi.org/10.1136/bmjmed-2023-000651

Sekerak, R., Lerner, J. B.-A., Prasad, P., & Prasad, M. (2023). Should I start an SGLT-2 inhibitor in my patient with heart failure and chronic kidney disease? Cleveland Clinic Journal of Medicine, 90(10), 607–609. https://doi.org/10.3949/ccjm.90a.23004

Lim, F., Bellows, B. K., Tan, S. X., Aziz, Z., Woo Baidal, J. A., Kelly, A. S., & Hur, C. (2023). Cost-Effectiveness of Pharmacotherapy for the Treatment of Obesity in Adolescents. JAMA Network Open, 6(8), e2329178. https://doi.org/10.1001/jamanetworkopen.2023.29178

Stamatiades, G. A., D’Silva, P., Elahee, M., Viana, G. M., Sideri-Gugger, A., & Majumdar, S. K. (2023). Diabetic Ketoacidosis Associated with Sodium-Glucose Cotransporter 2 Inhibitors: Clinical and Biochemical Characteristics of 29 Cases. International Journal of Endocrinology, 2023, 1–7. https://doi.org/10.1155/2023/6615624

Sun, X., Zhang, Q., Kadier, K., Hu, P., Liu, X., Liu, J., Yan, Y., Sun, C., Yau, V., Lowe, S., Meng, M., Liu, Z., & Zhou, M. (2023). Association between diabetes status and breast cancer in US adults: findings from the US National Health and Nutrition Examination Survey. Frontiers in Endocrinology, 14. https://doi.org/10.3389/fendo.2023.1059303

Habes, M., Jacobson, A. M., Braffett, B. H., Rashid, T., Ryan, C. M., Shou, H., Cui, Y., Davatzikos, C., Luchsinger, J. A., Biessels, G. J., Bebu, I., Gubitosi-Klug, R. A., Bryan, R. N., & Nasrallah, I. M. (2023). Patterns of Regional Brain Atrophy and Brain Aging in Middle- and Older-Aged Adults With Type 1 Diabetes. JAMA Network Open, 6(6), e2316182. https://doi.org/10.1001/jamanetworkopen.2023.16182

Weiner, A., Zhang, M., Ren, S., Tchang, B., Gandica, R., & Murillo, J. (2023). Progression from prediabetes to type 2 diabetes mellitus in adolescents: a real world experience. Frontiers in Clinical Diabetes and Healthcare, 4. https://doi.org/10.3389/fcdhc.2023.1181729

Cohen, L. P., Isaza, N., Hernandez, I., Lewis, G. D., Ho, J. E., Fonarow, G. C., Kazi, D. S., & Bellows, B. K. (2023). Cost-effectiveness of Sodium-Glucose Cotransporter-2 Inhibitors for the Treatment of Heart Failure With Preserved Ejection Fraction. JAMA Cardiology, 8(5), 419. https://doi.org/10.1001/jamacardio.2023.0077

Voils, C. I., Gavin, K. L., Thorpe, C. T., Pabich, S. K., Reeve, B. B., Mian, G. J., Faacks, A., & Kronish, I. M. (2022). Validating a Self-Reported Medication Nonadherence Measure in the Context of Multiple Chronic Diseases and Routes of Medication Administration Among Patients with Type 2 Diabetes. Patient Preference and Adherence, Volume 16, 3119–3130. https://doi.org/10.2147/ppa.s382885

Butt, J. H., Dewan, P., DeFilippis, E. M., Biering-Sørensen, T., Docherty, K. F., Jhund, P. S., Kosiborod, M. N., Martinez, F. A., Bengtsson, O., Johansen, N. D., Langkilde, A. M., Sjöstrand, M., Vaduganathan, M., Solomon, S. D., Sabatine, M. S., Køber, L., Fiuzat, M., & McMurray, J. J. V. (2022). Effects of Dapagliflozin According to the Heart Failure Collaboratory Medical Therapy Score. JACC: Heart Failure, 10(8), 543–555. https://doi.org/10.1016/j.jchf.2022.03.009

White, N. H., Pan, Q., Knowler, W. C., Schroeder, E. B., Dabelea, D., Chew, E. Y., Blodi, B., Goldberg, R. B., Pi-Sunyer, X., Darwin, C., Schlögl, M., Nathan, D. M., Goldstein, B. J., Furlong, K., Smith, K. A., Mendoza, J., Wildman, W., Simmons, M., … Hivert, M.-F. (2022). The Effect of Interventions to Prevent Type 2 Diabetes on the Development of Diabetic Retinopathy: The DPP/DPPOS Experience. Diabetes Care, 45(7), 1640–1646. https://doi.org/10.2337/dc21-2417

Aroda, V. R., Krause-Steinrauf, H., Kazemi, E. J., Buse, J. B., Gulanski, B. I., Florez, H. J., Ahmann, A. J., Loveland, A., Kuhn, A., Lonier, J. Y., Wexler, D. J., Crandall, J. P., McKee, M. D., Behringer-Massera, S., Brown-Friday, J., Xhori, E., Ballentine-Cargill, K., Duran, S., … Behringer-Massera, S. (2022). Clinical and Metabolic Characterization of Adults With Type 2 Diabetes by Age in the Glycemia Reduction Approaches in Diabetes: A Comparative Effectiveness Study (GRADE) Cohort. Diabetes Care, 45(7), 1512–1521. https://doi.org/10.2337/dc21-2659

Khera, R., Schuemie, M. J., Lu, Y., Ostropolets, A., Chen, R., Hripcsak, G., Ryan, P. B., Krumholz, H. M., & Suchard, M. A. (2022). Large-scale evidence generation and evaluation across a network of databases for type 2 diabetes mellitus (LEGEND-T2DM): a protocol for a series of multinational, real-world comparative cardiovascular effectiveness and safety studies. BMJ Open, 12(6), e057977. https://doi.org/10.1136/bmjopen-2021-057977

Gurtan, A., Dominy, J., Khalid, S., Vong, L., Caplan, S., Currie, T., Richards, S., Lamarche, L., Denning, D., Shpektor, D., Gurinovich, A., Rasheed, A., Hameed, S., Saeed, S., Saleem, I., Jalal, A., Abbas, S., Sultana, R., Rasheed, S. Z., … Saleheen, D. (2022). Analyzing human knockouts to validate GPR151 as a therapeutic target for reduction of body mass index. PLOS Genetics, 18(4), e1010093. https://doi.org/10.1371/journal.pgen.1010093

Lumish, H. S., Kennel, P. J., Concha, D., Chung, A., Oren, D., Jain, S. S., Jennings, D. L., Clerkin, K. J., Fried, J. A., Raikhelkar, J., Yuzefpolskaya, M., Majure, D., Choe, J., Latif, F., Uriel, N., & Sayer, G. (2022). New-Onset Diabetes in Patients Post-Heart Transplantation; the Role of Hypertension and Novel Diabetic Medications. The Journal of Heart and Lung Transplantation, 41(4), S322. https://doi.org/10.1016/j.healun.2022.01.800

Prasad, M., Mark, V., Ligon, C., Dutia, R., Nair, N., Shah, A., & Laferrère, B. (2021). Role of the Gut in the Temporal Changes of β-Cell Function After Gastric Bypass in Individuals With and Without Diabetes Remission. Diabetes Care, 45(2), 469–476. https://doi.org/10.2337/dc21-1270